Efficacy and tolerability of ketoprofen in patients with coronary artery disease in the postoperative period after cardiac surgery, depending on the comorbid status


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Patients with coronary artery disease (CAD) undergoing cardiac surgery often have a number of comorbidities. The simultaneous use of a large number of drugs can affect the efficacy and safety of drugs used for pain relief. Objective. Evaluation of the efficacy and tolerability of ketoprofen in CAD patients in the postoperative period after cardiac surgery, depending on the comorbid status. Methods. The study included 90 CAD patients in the early postoperative period. Cardiac surgery was performed according to the following indications: clinically significant coronary stenosis, valvular heart disease (stenosis and/or insufficiency of the aortic, mitral, tricuspid valves), aortic aneurysm. Postoperative analgesia was performed using ketoprofen 200 mg/day. The effectiveness of ketoprofen was evaluated by analyzing the intensity of postoperative pain syndrome. Ketoprofen tolerance was assessed by analyzing the incidence of acute renal injury, NSAID-associated dyspepsia, and hepatotoxic reactions in the postoperative period. The intensity of the pain syndrome was assessed using a digital rating scale. The Charlson index was used to quantify the comorbid status. Statistical analysis was performed using the Mann-Whitney test, Fisher’s exact test, and Pearson’sx2 test. Results. Moderate comorbidity was significantly more common in patients under 60 years of age compared to patients over 60 years of age: 19 (73%) and 9 (14%) patients (p<0.001), respectively. High comorbidity was noted in the older age group: 58 (90.6%) and 6 (23%) patients in the groups of 60 and over and under 60 years of age, respectively (p<0.001). There were no significant differences in the intensity of the pain syndrome depending on the degree of comorbidity. There were also no significant differences in adverse effects during anesthesia with ketoprofen, depending on the degree of comorbidity and the number of drugs taken simultaneously. Conclusion. Significant differences in the degree of comorbidity depending on the age group were revealed: moderate comorbidity was significantly more common in patients under the age of 60 years (P<0.001), high comorbidity - in patients over 60 years of age (P<0.001). There were no significant differences in the intensity of the pain syndrome and adverse effects during anesthesia with ketoprofen, depending on the degree of comorbidity.

Full Text

Restricted Access

About the authors

T. E Morozova

Sechenov University

Moscow, Russia

Dmitry A. Shatskiy

Sechenov University

Email: dmshatsk@gmail.com
Postgraduate Student, Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, Institute of Clinical Medicine Moscow, Russia

T. B Andruschishina

Sechenov University

Moscow, Russia

M. V Lukina

Sechenov University

Moscow, Russia

V. P Fisenko

Sechenov University

Moscow, Russia

D. A Sychev

Russian Medical Academy of Continuous Professional Education

Moscow, Russia

References

  1. Оганов Р.Г., Денисов И.Н., Симаненков В.И. и др. Коморбидная патология в клинической практике. Клинические рекомендации. Кардиоваскулярная терапия и профилактика. 2017;16(6):5-56. doi: 10.15829/1728-8800-201 7-6-5-56.
  2. Huxley R., Barzi F., Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37prospective cohort studies. BMJ. 2006;332(7533):73-8. doi: 10.1136/bmj.38678.389583.7C.
  3. Man S.F, Leipsic J.A., Man J.P, Sin D.D. Is atherosclerotic heart disease in COPD a distinct phenotype? Chest. 2011;140(3):569-71. doi: 10.1378/chest.11-0928.
  4. Magro L., Moretti U., Leone R. Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions. Exp Opin Drug Saf. 2012;11(1):83-94. doi: 10.1517/14740338.2012.63191.
  5. Payne R.A., Avery A.J., Duerden M., et al. Prevalence of polypharmacy in a Scottish primary care population. Eur J Clin Pharmacol. 2014;70(5):575-81. doi: 10.1007/s00228-013-1639-9.
  6. Барбараш О.Л., Семенов В.Ю., Самородская И.В. и др. Коморбидная патология у больных ишемической болезнью сердца при коронарном шунтировании: опыт двух кардиохирургических центров. Российский кардиологический журнал. 2017;(3):6-13. Doi. 10.15829/1560-4071-2017-3-6-13.
  7. Chou A.H., Chen TH, Chen C.Y., et al. Long-Term Outcome of Cardiac Surgery in 1,040 Liver Cirrhosis Patient Nationwide Population-Based Cohort Study. Circ J. 2017;81(4):476-84. doi: 10.1253/circj.CJ-16-0849.
  8. Ghanta R.K., LaPar D.J., Zhang Q., et al. Obesity Increases Risk-Adjusted Morbidity, Mortality, and Cost Following Cardiac Surgery. J Am Heart Assoc. 2017;6(3):e003831. doi: 10.1161/JAHA.116.003831.
  9. Rocca W.A., Boyd C.M., Grossardt B.R., et al. Prevalence of multimorbidity in a geographically defined American population: patterns by age, sex, and race/ethnicity. Mayo Clin Proc. 2014;89(10):1336-49. doi: 10.1016/j.mayocp.2014.07.010.
  10. Guimaräes-Pereira L., Reis P., Abelha F., et al. Persistent postoperative pain after cardiac surgery: a systematic review with meta-analysis regarding incidence and pain intensity. Pain. 2017;158(10):1869-85. doi: 10.1097/j.pain.0000000000000997.
  11. van Dijk G.M., Veenhof C., Schellevis F., et al.Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee. BMC. Musculoskelet Disord. 2008;9:95. doi: 10.1186/1471-2474-9-95.
  12. de Luca K.E., Parkinson L., Haldeman S., et al. The Relationship Between Spinal Pain and Comorbidity: A Cross-sectional Analysis of 579 Community-Dwelling, Older Australian Women. J Manipulat Physiol Ther. 2017;40(7):459-66. doi: 10.1016/j.jmpt.2017.06.004.
  13. Овечкин А.М., Баялиева А.Ж., Ежевская А.А. и др. Послеоперационное обезболивание. Клинические рекомендации. Вестник интенсивной терапии им. А.И. Салтанова. 2019;(4):9-33.doi: 10.21320/1818-474X-2019-4-9-33.
  14. Каратеев А.Е., Насонов Е.Л., Ивашкин В.Т. и др. Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации. Научно-практическая ревматология. 2018;56:1-29. doi: 10.14412/1995-4484-2018-1-29.
  15. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephr Clin Pract. 2012;120(4):179-84. doi: 10.1159/000339789.
  16. European Association for the Study of the Liver. Clinical Practice Guideline Panel: Chair: Panel members; EASL Governing Board representative. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol. 2019;70(6):1222-61. doi: 10.1016/j.jhep.2019.02.014.
  17. Kulich K.R., Madisch A., Pacini F., et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual. Life Outcomes. 2008;31(6):12. doi: 10.1186/1477-7525-6-12.
  18. Charlson M., Szatrowski T.P., Peterson J., Gold J. Validation of a combined comorbidity in-dex. J Clin Epidemiol. 1994;47(11):1245-51. doi: 10.1016/0895-4356(94)90129-5.
  19. Бойцов С.А., Баланова Ю.А., Шальнова С.А. и др. Артериальная гипертония среди лиц 25-64 лет: распространенность, осведомленность, лечение и контроль. По материалам исследования ЭССЕ. Кардиоваскулярная терапия и профилактика. 2014;4:414. doi: 10.15829/1728-8800-2014-4-4-14.
  20. Смирнов А.В., Шилов Е.М., Добронравов В.А. и др. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Нефрология. 2012;16(1):89-115. doi: 10.24884/1561-6274-2012-16-1-89-115.
  21. van Oostrom S.H., Gijsen R., Stirbu I., et al. Time Trends in Prevalence of Chronic Diseases and Multimorbidity Not Only due to Aging: Data from General Practices and Health Surveys. PLoS One. 2016;11(8):e0160264. doi: 10.1371/journal.pone.0160264.
  22. Wolfe F., Ablin J., Guymer E.K., et al. The Relation of Physical Comorbidity and Multimor-bidity to Fibromyalgia, Widespread Pain, and Fibromyalgia-related Variables. J Rheumatol. 2020;47(4):624-31. doi: 10.3899/jrheum.190149.
  23. Ferguson M., Svendrovski A., Katz J. Association Between Multimorbid Disease Patterns and Pain Outcomes Among a Complex Chronic Care Population in Canada. J Pain Res. 2020;13:3045-57. 57. doi: 10.2147/JPR.S269648.
  24. Melkevik O., Clausen T., Pedersen J., et al.Comorbid symptoms of depression and musculoskeletal pain and risk of long term sickness absence. BMC. Publ Health. 2018;18(1):981. doi: 10.1186/s12889-018-5740-y.
  25. Athar W., Card M.E., Charokopos A., et al. Obstructive Sleep Apnea and Pain Intensity in Young Adults. Ann Am Thorac Soc. 2020;17(10): 1273-78. doi: 10.1513/AnnalsATS.201910-750OC.
  26. Ho K.M., Bham E., Pavey W. Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2015;4(10):e002652. doi: 10.1161/JAHA.115.002652.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies